Lv5
985 积分 2021-06-02 加入
Proteogenomic characterization of primary colorectal cancer and metastatic progression identifies proteome-based subtypes and signatures
13天前
已完结
Single-cell and spatial genomic landscape of non-small cell lung cancer brain metastases
13天前
已完结
A systematic analysis of immune escape signals in the primary and metastatic tumor genome
13天前
已完结
Spatially resolved transcriptomic analysis of the adult human prostate
22天前
已完结
Spatially resolved transcriptomic analysis of the adult human prostate
28天前
已完结
Nivolumab plus cabozantinib versus sunitinib in first-line treatment for advanced renal cell carcinoma (CheckMate 9ER): long-term follow-up results from an open-label, randomised, phase 3 trial
1个月前
已完结
Patient-reported outcomes with first-line nivolumab plus cabozantinib versus sunitinib in patients with advanced renal cell carcinoma treated in CheckMate 9ER: an open-label, randomised, phase 3 trial
1个月前
已完结
Avelumab plus axitinib versus sunitinib in advanced renal cell carcinoma: biomarker analysis of the phase 3 JAVELIN Renal 101 trial
1个月前
已完结
Pembrolizumab plus axitinib versus sunitinib monotherapy as first-line treatment of advanced renal cell carcinoma (KEYNOTE-426): extended follow-up from a randomised, open-label, phase 3 trial
1个月前
已完结
Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial
1个月前
已完结
皖公网安备34019202002308
